Jonathon Kellerman has joined Actavis as Executive Vice President, Global Chief Compliance Officer.
Kellerman is a member of the Actavis Executive Leadership Team (ELT) and will report directly to Brent Saunders, CEO and President. He will also be an integral member of the Actavis and Allergan pre-integration planning team as well as integration activities following the close of the takeover.
Kellerman joins Actavis from PwC, where he was a partner in PwC's Pharmaceutical and Life Sciences Advisory practice, responsible for helping lead the firm's Governance, Risk & Compliance practice, including a global team of more than 100 people. He brings extensive experience in compliance and sales and marketing performance improvement, including global anti-bribery/anti-corruption programme assessment, design and implementation work; building and implementing effective global compliance programmes; managing fraud investigations and remediation activities; re-engineering processes supporting key commercial and R&D business activities and compliance controls; and re-designing how companies engage healthcare professionals.
Earlier in his career, Kellerman worked in healthcare consulting for Zelenkofske Axelrod and in research for Blank Rome.
